Antibiotic resistance has emerged as a significant global health threat, with projections suggesting that over 10 million people could die annually by 2050 due to resistant infections. A recent study from researchers at the University of California, San Diego (UCSD) has introduced a promising solution to this crisis. The team developed a novel CRISPR-based technology aimed at removing antibiotic-resistant genetic elements from bacterial populations, as detailed in their publication in npj Antimicrobials and Resistance.
The new tool, named pPro-MobV, is a second-generation technology linked to the concept of gene drives, which are often used in insect populations to hinder the spread of harmful traits. According to Ethan Bier, PhD, a distinguished professor in the department of cell and developmental biology at UCSD, “With pPro-MobV, we have brought gene-drive thinking from insects to bacteria as a population engineering tool.” This innovation allows researchers to neutralize antibiotic resistance across large populations by utilizing just a few cells.
In 2019, Bier’s laboratory, in collaboration with Victor Nizet, MD, who is a distinguished professor at the UCSD School of Medicine, began developing the initial Pro-AG concept. This involved introducing a genetic cassette that copies itself between bacterial genomes to inactivate antibiotic-resistant components. The new system enhances this process by facilitating the spread of the antibiotic CRISPR cassette through conjugal transfer, enabling effective distribution among bacterial communities.
Innovative Approach to Combat Biofilms
The research demonstrated that the pPro-MobV system can exploit naturally occurring bacterial mating tunnels to disseminate essential disabling elements. The findings are particularly significant given that bacterial biofilms—communities of microorganisms that create protective layers—pose a major challenge in both clinical settings and environments such as sewage treatment plants and aquafarms. These biofilms are often resistant to conventional cleaning methods and can be implicated in serious infections.
Bier emphasizes the importance of addressing biofilms in the fight against antibiotic resistance, noting, “This is one of the most challenging forms of bacterial growth to overcome in the clinic.” The study highlights the potential applications of pPro-MobV in healthcare, environmental remediation, and microbiome engineering.
Additionally, the researchers discovered that components of this active genetic system could be delivered by bacteriophages, which are viruses that specifically infect bacteria. The team envisions deploying pPro-MobV in conjunction with engineered phage viruses to enhance its effectiveness. The genetic platform also includes safety measures, such as homology-based deletion, which allows for the removal of the gene cassette if necessary.
Significance of the Findings
Justin Meyer, PhD, a professor in the department of ecology, behavior, and evolution at UCSD and co-author of the study, remarked on the breakthrough nature of this technology. “This technology is one of the few ways that I’m aware of that can actively reverse the spread of antibiotic-resistant genes, rather than just slowing or coping with their spread.”
The development of the pPro-MobV tool represents a significant advancement in the ongoing battle against antibiotic resistance, offering hope for more effective treatments and strategies to combat one of the most pressing public health challenges of our time. The ongoing research promises to reveal further implications for the future of microbial management in both health and environmental contexts.